Medlive Technology (02192) Announces Monthly Share Capital Movements for November 2025

Bulletin Express
2025/12/01

Medlive Technology Co., Ltd. (Stock Code: 02192) published its monthly return for the period ended 30 November 2025. The authorized share capital remained at 50,000,000,000 ordinary shares, each valued at USD 0.00001, maintaining a total authorized share capital of USD 500,000.

The total issued shares likewise stood at 734,793,375, showing no movements during the reporting period. Under the Pre-IPO Share Option Scheme, 5,481,125 share options remained outstanding; no new shares were issued, and the Post-IPO Share Option Scheme indicated that 69,017,600 shares may be issued upon exercise of granted options.

The company confirmed compliance with relevant listing rules and regulations. No other changes in treasury shares or warrant-related movements were announced for November 2025.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10